STLN logo

STLN Starling Oncology, Inc.

NASDAQ · Medical - Care Facilities · Healthcare

$3.19
+0.01 (+0.45%)

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across m…

Market Cap: $325.79Mwww.starlingoncology.com

Price

No data yet.

Social Signal Score

55
5d
—
30d
53
4 mentions
—
60d
56
6 mentions
—
90d
56
6 mentions
—
news: 6

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 0Sell 0Strong Sell 0
Avg price target$9+181.8%
Low $9Median $9High $9
Current Consensus

Revenue

$169.77M+24.31%
$136.56M$147.63M$158.70M$169.77M
Sep 30Sep 30

Analyst Estimates

FY2025
$-0.59
$-0.59–$-0.58
1 analysts
FY2026
$-0.27
$-0.27–$-0.26
2 analysts
FY2027
$-0.09
$-0.09–$-0.08
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Daniel Virnich
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
641
Beta
0.42
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
1.74
www.starlingoncology.com